Using synthetic biology and AI to address global antimicrobial resistance threat
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease.
MagMix, an onboard mixing device, enables scalable manufacturing of 3D-printed tissues.
Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
WITEC is working to develop the first wearable ultrasound imaging system to monitor chronic conditions in real-time, with the goal of enabling earlier detection and timely intervention.
Researchers uncover a hidden mechanism that allows cancer to develop aggressive mutations.
Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.
Time and again, an unassuming roundworm has illuminated aspects of biology with major consequences for human health.
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
New research demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data.
MIT community members made headlines with key research advances and their efforts to tackle pressing challenges.
The Hood Pediatric Innovation Hub brings together clinicians, researchers, and industry to bridge the gap between discovery and care.
Angela Koehler, Iain Cheeseman, and Katharina Ribbeck are shaping the collaborative as a platform for transformative research, translation, and talent development across MIT.
A study profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking a treatment-resistant and deadly brain cancer.
New findings may help researchers identify genetic mutations that contribute to rare diseases, by studying when and how single genes produce multiple versions of proteins.